Neurix is at the forefront of stem cell research, constantly innovating to expand access to novel technologies and accelerate drug development.
Our services deliver tailored solutions to answer key questions about drug efficiency and biological mechanisms, empowering confident preclinical decisions.
With our expert team, you receive cost-effective, precise screening results that save time and reduce reliance on animal testing and human trials.
Individual
service design
Project
execution
Readouts
Analysis
Glioblastoma-organoid assembloids to assess drug efficiency on tumour growth, motility, and metastasis, while also testing effects on healthy tissue using organoids.
Assessing compound penetration efficiency using transwells seeded with iPSC-derived human brain microvascular endothelial cells to enhance biological relevance.
Human organoid model with disease-specific readouts: morphology, protein aggregation and β-amyloid immuno-reactivity.
Human organoid model with disease-specific readouts: morphology, protein and α-synuclein aggregation.
Human organoid model for drug discovery services and personalised development of in vitro disease models, assays, and in depth -omics analyses.
